Future Pharmacy‐Based Chlamydia Screening: Consumer Preference

Abstract

ABSTRACTBackgroundChlamydia trachomatis is the most prevalent sexually transmitted infection in Australia and a serious public health concern. Barriers to screening for C. trachomatis include high costs, clinic waiting times, inconvenience, fear of medical procedures, stigma and lack of privacy. Advances in nucleic acid amplification techniques have enabled the choice of 2 self‐collected and non‐invasive sampling methods for detecting C. trachomatis: first‐void urine and low vaginal swab.AimTo determine whether women prefer first‐void urine or low vaginal swab for detecting C. trachomatis.MethodA self‐administered survey was piloted and refined. Women from a university and a shopping centre were invited to participate in the survey. The survey gathered data on demographics, previous experiences with sample collection and preference for a future pharmacy‐based chlamydia screening intervention. Participants completed the survey independently and sealed it in the envelope provided.ResultsMedian age of the 100 female participants was 22 (range 20–23) years. 58% preferred to collect first‐void urine and 42% preferred a low vaginal swab. Almost half of the women noted it would be easy to collect both samples. Of the 40 women with previous experience of collecting a first‐void urine sample, significantly more would prefer low vaginal swabs in the future (p = 0.02).ConclusionWomen did not prefer one method of sample collection over the other. Both sampling methods were either ‘very easy’ or ‘easy‘.